Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 562

• Price / Volume Information    Yesterday's Closing Price: $19.17 Daily Weekly Monthly 20 Day Moving Average: 121,446 shares Shares Outstanding: 25.08 (millions) Market Capitalization: $480.73 (millions) Beta: 1.07 52 Week High: $26.40 52 Week Low: $15.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 9.79% 10.75% 12 Week 4.13% 4.00% Year To Date 7.94% 7.42%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 philip@gilmartinir.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Terry D. Schlotterback - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/06/26 Share - Related Items Shares Outstanding: 25.08 Most Recent Split Date: (:1) Beta: 1.07 Market Capitalization: $480.73 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.26 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.15 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.38 Price/Cash Flow: - Price / Sales: 2.03 EPS Growth vs. Year Ago Period: 10.34% vs. Previous Quarter: -8.33% Sales Growth vs. Year Ago Period: 16.97% vs. Previous Quarter: 0.58% ROE 12/31/25 - -6.68 09/30/25 - -6.86 06/30/25 - -6.36 ROA 12/31/25 - -4.79 09/30/25 - -4.97 06/30/25 - -4.69 Current Ratio 12/31/25 - - 09/30/25 - 7.40 06/30/25 - 6.66 Quick Ratio 12/31/25 - - 09/30/25 - 3.52 06/30/25 - 3.43 Operating Margin 12/31/25 - -9.91 09/30/25 - -10.61 06/30/25 - -10.28 Net Margin 12/31/25 - -16.77 09/30/25 - -20.06 06/30/25 - -18.92 Pre-Tax Margin 12/31/25 - - 09/30/25 - -20.16 06/30/25 - -19.51 Book Value 12/31/25 - - 09/30/25 - 13.93 06/30/25 - 14.64 Inventory Turnover 12/31/25 - - 09/30/25 - 0.52 06/30/25 - 0.52 Debt-to-Equity 12/31/25 - - 09/30/25 - 0.28 06/30/25 - 0.27 Debt-to-Capital 12/31/25 - - 09/30/25 - 21.68 06/30/25 - 21.34

Powered by Zacks Investment Research ©